about
The therapeutic use of heroin: a review of the pharmacological literaturePlasma concentration and urinary excretion of guanidine derivatives in normal subjects and patients with renal failureTopical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development.Topical and peripherally acting analgesics.Adenosine in the spinal cord and periphery: release and regulation of pain.Pain catastrophizing predicts poor response to topical analgesics in patients with neuropathic pain.Topical analgesics in neuropathic pain.A randomized controlled trial of qigong for fibromyalgia.Adenosine and ATP receptors.Extension trial of qigong for fibromyalgia: a quantitative and qualitative study.A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain.Methylxanthines and pain.Caffeine and pain.Nontricyclic antidepressant analgesics and pain: are serotonin norepinephrine reuptake inhibitors (SNRIs) any better?Contributions of peripheral, spinal, and supraspinal actions to analgesia.Topical and peripheral ketamine as an analgesic.Topical analgesics for neuropathic pain in the elderly: current and future prospects.Qigong and fibromyalgia: randomized controlled trials and beyondAdenosine A1 receptor-dependent antinociception induced by inosine in mice: pharmacological, genetic and biochemical aspects.Adenosine receptor targets for pain.Qualitative analysis of a controlled trial of qigong for fibromyalgia: advancing understanding of an emerging health practice.Reduction of formalin-evoked responses and maintenance of peripheral antinociception by morphine against formalin in the spared nerve injury model.Intravenous adenosine alleviates neuropathic pain: a double blind placebo controlled crossover trial using an enriched enrolment design.Perisurgical amitriptyline produces a preventive effect on afferent hypersensitivity following spared nerve injury.Amitriptyline enhances extracellular tissue levels of adenosine in the rat hindpaw and inhibits adenosine uptake.Intracerebroventricular morphine releases adenosine and adenosine 3',5'-cyclic monophosphate from the spinal cord via a serotonergic mechanism.Qigong and Fibromyalgia circa 2017.Classification of adenosine receptors mediating antinociception in the rat spinal cord.Supersensitivity to intrathecal 5-hydroxytryptamine, but not noradrenaline, following depletion of spinal 5-hydroxytryptamine by 5,7-dihydroxytryptamine administered into various sites.Caffeine reverses antinociception by oxcarbazepine by inhibition of adenosine A1 receptors: insights using knockout mice.Chaoyi Fanhuan Qigong and fibromyalgia: methodological issues and two case reports.Peripheral amitriptyline suppresses formalin-induced Fos expression in the rat spinal cord.Intraplantar injection of glutamate evokes peripheral adenosine release in the rat hind paw: involvement of peripheral ionotropic glutamate receptors and capsaicin-sensitive sensory afferents.The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration.Modulation of formalin-induced behaviors and edema by local and systemic administration of dextromethorphan, memantine and ketamine.Peripheral interactions between dextromethorphan, ketamine and amitriptyline on formalin-evoked behaviors and paw edema in rats.Peripheral antihyperalgesic and analgesic actions of ketamine and amitriptyline in a model of mild thermal injury in the rat.8-Phenyltheophylline reverses the antinociceptive action of morphine in the periaqueductal gray.Intrathecal but not intravenous opioids release adenosine from the spinal cord.Spinal and peripheral adenosine A₁ receptors contribute to antinociception by tramadol in the formalin test in mice.
P50
Q22299321-61F151B2-28CC-405C-8A5B-D3F37496A2DFQ28338007-F35ECAFF-A758-4E85-96FF-E64B30C83346Q34376548-9FDC9656-8195-4777-A5FE-7630A4C8FA87Q35077435-4832D3A6-67D5-4AE1-B559-1367B1F0731CQ35145661-A9004AB6-48A7-4412-AB57-3DBE50A68068Q35820565-53DC4A22-8805-4573-8118-784D461C81FAQ36264629-DCF3FDF2-FCA8-46B2-A4BC-78338C0B9330Q36633380-B9FF1A68-556A-4F57-9980-9E6B00F07D3FQ36646033-B6E7F75D-E6F0-489C-81B1-7C0D165C8F4FQ37166680-7DC97367-CCE3-40C0-A5A3-AF900EA70909Q37767601-CF1BD504-8FB3-4F5D-B84C-8FFF404D6888Q37791048-65B3F05E-8EAC-415F-8F65-BB1BE60EEC64Q37805863-8DE2D3CF-7E17-4760-85BB-D061503860BBQ37896842-28581977-C691-4E35-8BDB-A2A0B76A0129Q38204556-9134F4CE-B8DA-4E34-BBD9-7FA84A561ED4Q38221520-3A0BA632-B06C-4F9F-8261-BD551059CAE3Q38265422-865D3D75-298B-4CC5-8673-F922371D1182Q38283548-6BAAE183-B5D3-428E-9CC3-FBEDA36E3593Q38305482-E8957D19-7958-482B-9DC7-D5CF57E96BF1Q38616219-CE766054-867C-4A2B-94F6-F9D955ECDCABQ39152036-D9BD29B6-9BFD-45E1-B0A0-3B597BEFC765Q39270100-1ADD014C-839A-4A31-98A3-0F57CDA1097DQ39395034-2616BEE5-8380-4D26-BB7D-D1EB7E0E13A8Q39800507-0FCC690B-B51A-47E5-B99C-9190824AD141Q40374840-3EB2BD35-4339-4CA3-B225-8784E1E8CCC5Q41131818-B341AF6B-81C8-4280-A03F-83A2A03A1F58Q41528958-642B5D86-49F0-4982-90A6-65B0BDF959E8Q41841691-53914292-033E-4868-90EA-75C07831311BQ41851776-AB14BBBC-9741-4037-A58B-B5985F7A40CFQ43153861-BE33B1DD-4FD4-4D96-8C43-73E67903AD10Q43743739-1196B05A-0482-48D0-B233-F54918FD0B3CQ43867483-2EAF356A-8D1F-4A47-883E-CACFD926B8F4Q43883805-CCDECBD9-D346-4C03-B9DA-61C1D4E09EA4Q43935282-91ACE61B-7241-4AA0-87D5-03FD6AE39078Q44121975-5D311633-21CB-427D-9D46-6F192BAD261EQ44349870-7311D1A3-DF5A-4B44-A18B-921636808785Q44486065-B2AF2474-7AC5-4B9F-B0FA-251F21284DC9Q44752702-72893B5C-2ED5-4FEB-8C66-450E665287D2Q44771162-0C0430B9-E112-436E-9021-66984FD19B3CQ44909056-BE13321B-AB6A-445B-B025-FE7D2389F40A
P50
description
researcher ORCID ID = 0000-0003-3792-834X
@en
wetenschapper
@nl
name
Jana Sawynok
@ast
Jana Sawynok
@en
Jana Sawynok
@es
Jana Sawynok
@nl
type
label
Jana Sawynok
@ast
Jana Sawynok
@en
Jana Sawynok
@es
Jana Sawynok
@nl
prefLabel
Jana Sawynok
@ast
Jana Sawynok
@en
Jana Sawynok
@es
Jana Sawynok
@nl
P31
P496
0000-0003-3792-834X